Amgen Inc (BSP:AMGN34)
R$ 58.14 0 (0%) Market Cap: 881.03 Bil Enterprise Value: 1.20 Til PE Ratio: 34.15 PB Ratio: 19.04 GF Score: 86/100

Q1 2019 Amgen Inc Earnings Call Transcript

Apr 30, 2019 / 09:00PM GMT
Release Date Price: R$25.72
Operator

My name is Ian, and I will be your conference facilitator today for Amgen's First Quarter 2019 Financial Results Conference Call. (Operator Instructions)

I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.

Arvind Sood
Amgen Inc. - VP of IR

Okay. Thanks, Ian. Good afternoon, everybody. Thanks for joining us today on our first quarter call. Special welcome to those who are new in their coverage of our company, including Jay Olson of Oppenheimer, Yaron Werber of Cowen and Do Kim of BMO.

So we go into 2019 having put in place a strong track record of execution, and we are well prepared for the challenges and opportunities ahead. I am joined today by our Chairman and CEO, Bob Bradway, who will provide a strategic overview of our business and the environment we operate in. After Bob's comments, our CFO, David Meline, will review our financial results for the first quarter. Our Head of Global Commercial Operations, Murdo Gordon, will then review our product performance, followed by our Head

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot